fashion -WSS

fashion

author：entertainment 2025-08-11 09:47:40 - browse：92571

a doctor wraps a smart watch around a patient's wrist — Adobe

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.

Founded in 2017, HumanFirst maintains a meticulously organized library of digital measurement tools, their underlying evidence, and information about how they have been used in clinical trials. Called Atlas, the platform is designed so that a trial sponsor can research what tools are available to measure things like physical activity or sleep for many commonly studied diseases. CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols.

Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services. As of 2021, HumanFirst had raised $15 million in venture capital funding, and the decision to sell to Icon for an undisclosed amount comes as some big drug companies are reevaluating their approach to digital technologies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： The painfully weak evidence on taking collagen to treat arthritis

focus

WSS

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Germany receives 178 compensation applications from gay servicepeople over discrimination

‘The Bear’ and hospitality in hospitals

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

hotspot

fashion

explore

Alkermes shareholders re

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

What does generative AI mean for health care? We asked experts

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

After affirmative action ruling, medical educators look to 'holistic review'

Let's speed up science by embracing open access publishing

Affirmative action in medical school literally saved lives

Hospitals use virtual reality to design more inclusive rooms for kids

Jerome Adams on the need for new antivirals for Covid

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

entertainment

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

The painfully weak evidence on taking collagen to treat arthritis

Woman returns to dialysis after doctors remove transplanted pig kidney

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

hotspot

focus

Wikipedia

explore